AWM
ADMA icon

Avior Wealth Management’s ADMA Biologics ADMA Stock Holding History

Avior Wealth Management’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-17,061
Closed -$311K – 828
2025
Q4 		$311K Buy
17,061
+6,741
+65% +$114K 0.01% 603
2025
Q3 		$151K Buy
+10,320
New +$177K ﹤0.01% 701
2025
Q1 		– Sell
-585
Closed -$10K – 760
2024
Q4 		$10K Hold
585
– – ﹤0.01% 1620
2024
Q3 		$11.7K Sell
585
-423
-42% -$6.58K ﹤0.01% 1504
2024
Q2 		$11.3K Buy
1,008
+24
+2% +$201 ﹤0.01% 1479
2024
Q1 		$6.49K Buy
+984
New +$5.38K ﹤0.01% 2002

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Avior Wealth Management's ADMA Position: Q1 2026 in Review

Avior Wealth Management sold out of ADMA Biologics (ADMA) in Q1 2026, closing a stake of 17,061 shares — an estimated $311K sold.

Avior Wealth Management first reported a position in ADMA in Q1 2024 and held it in 6 quarters. The position peaked at $311K in Q4 2025. 357 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Avior Wealth Management reported no remaining ADMA Biologics position as of Q1 2026 after selling out during the quarter.
  • Avior Wealth Management sold 17,061 ADMA Biologics shares in Q1 2026, an estimated $311K.
  • Avior Wealth Management first reported a position in ADMA Biologics in Q1 2024 and held it in 6 quarters.
  • Avior Wealth Management's ADMA Biologics position peaked at $311K in Q4 2025.
  • 357 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Avior Wealth Management's 13F filing for Q1 2026, filed 9 Apr 2026.